[1]
George, G. et al. 2021. Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden. Acta Oncologica. 60, 4 (Apr. 2021), 459–465. DOI:https://doi.org/10.1080/0284186X.2021.1885058.